Biofrontera Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Hermann Luebbert, with a market cap of $10.2M.
Based on Q1 2026 filing
Common questions about Biofrontera Inc.
Biofrontera Inc. (BFRI) has a market capitalization of $10.2M and trades on NASDAQ.
Biofrontera Inc. has approximately 85 employees.